Percutaneous Coronary Intervention Outcomes Among Patients With Alcoholic Cardiomyopathy: An Analysis of the National Inpatient Sample

• Type of Material: Article
• Authors: Endurance O Evbayekha, St. Luke's Hospital, St. Louis, USA; Bede N Nriagu, Metropolitan Hospital Center; Gabriel Alugba, Delta State University, Nigeria; Okelue E Okobi, Lakeside Medical Center, Belle Glade, USA; Ovie Okorare, Delta State University, Nigeria; Geraldine Nsofor, Milton Keynes University Hospital; Ihuoma A Ngoladi, Independent Researcher, Calgary; Chinelo Igweike, RBH Medical Center; Maureen G Boms, University of Alabama at Birmingham; Nkemputaife P Onyechi, University Hospitals Cleveland Medical Center; Aisha M Abubakar, University of Maiduguri; Eniola Olamilehin, St. George's University; Akinbanji R Afolabi, Emory University; Uduak A Udo, Imaging for Women, Kansas City; Evidence E Ohikhuai, Jackson State University
• Language: English
• Date: 2022-09-23
• Publisher: Cureus, Inc.
• Publication Version: Final Published Version
• Copyright Statement: © 2022, Evbayekha et al.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.7759/cureus.29490
• Title of Journal or Parent Work: Cureus
• Volume: 14
• Issue: 9
• Keywords: average length of hospital stay; nationwide inpatient sample (nis); primary percutaneous coronary intervention (pci); outcome measure; alcohol dependence; inpatient outcomes; percutaneous coronary intervention; alcoholic cardiomyopathy
• Research Categories: Health Sciences, Medicine and Surgery

Abstract

High consumption of alcohol has an enormous toll on the health status of individuals. A direct affectation of cardiac integrity concerns cardiologists, primary care physicians, and the healthcare system because this increases the disease burden. Alcoholic cardiomyopathy (ACM) results from the enormous consumption of alcohol over a long period of time. The prevalence varies between regions and sex and ranges between 4% and 40%. Viewing the entire spectrum of cardiomyopathies, ACM makes up about 4% of all cardiomyopathies. However, it causes dilated-type cardiomyopathy and is the second most common cause of dilated cardiomyopathy. We sought to explore the outcomes of percutaneous coronary intervention (PCI) among patients with ACM.